Press Release

Myomo Welcomes 13 New Center of Excellence Locations

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced the addition of three new orthotics and prosthetics (O&P) practices and 13 new locations to its MyoPro Center of Excellence (CoE) program, which recognizes top O&P practices that support the MyoPro line of powered orthoses. The…

Read More

Myomo, Inc. Issues March 2018 Shareholder Letter

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today issued a letter to shareholders to give an update on fourth quarter 2017 and ongoing MyoPro® commercial activities. Read more.

Read More

Myomo Reports Fourth Quarter and Year End 2017 Results

CAMBRIDGE, Mass., March 7, 2018 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today reports its financial results for the fourth quarter and year end December 31, 2017. Read more.

Read More

Myomo to Present at the 30th Annual ROTH Conference

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that it will be presenting at the 30th Annual ROTH Conference in Dana Point, CA on Monday, March 12th at 9:00 AM PT, Blue – Salon 2. Chairman and Chief Executive Officer Paul R. Gudonis will be…

Read More

Myomo to Report Fourth Quarter and Year End 2017 Results on March 7, 2018

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that it will release its financial results for the fourth quarter and year end December 31, 2017 results on Wednesday, March 7, 2018, after the US markets close. Read more.

Read More

Myomo and GRE to Conduct Screening Days in Ohio and Detroit

Free, Convenient Hands-on Trial of MyoPro® Powered Brace CAMBRIDGE, Mass. & CHARDON, Ohio–(BUSINESS WIRE)–Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, and Geauga Rehabilitation Engineering (GRE) have announced a series of free screening days to be held at the offices of GRE and its local partners near Cleveland,…

Read More

Myomo Completes Repayment of Loan to the Massachusetts Life Sciences Center

CAMBRIDGE, Mass., January 24, 2018 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, and the Massachusetts Life Sciences Center (MLSC) today celebrated Myomo’s repayment of a $750,000 accelerator loan provided by the MLSC in 2011. Myomo completed repayment of the loan, which totaled $1,350,618 with interest, on…

Read More

Myomo to Present at Noble Capital Markets’ 14th Annual Investor Conference

Cambridge, MA., January 16, 2018 – Myomo, Inc. (NSYE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that it will be presenting at NobleCon14 – Noble Capital Markets’ Fourteenth Annual Investor Conference at the W Hotel, Fort Lauderdale, Florida on Monday, January 29th at 11:00 AM EST – Studio…

Read More

Myomo, Inc. Announces Full Exercise of Underwriter’s Over-allotment Option in Follow-on Public Offering

CAMBRIDGE, Mass., December 6, 2017 – Myomo, Inc. (NYSE American: MYO), a commercial stage medical robotics company, today announced that Roth Capital Partners, the underwriter of Myomo’s follow-on offering, exercised in full its option to purchase 626,250 shares of common stock and accompanying warrants to purchase 626,250 shares of common stock, at a combined price…

Read More